Live Quote · NASDAQBTAIHealthcare· Biotechnology

BioXcel Therapeutics, Inc.

$0.07▲ 64.22%(+$0.03)
MKT CAP $2.28MLAST EARNINGS Nov 11, 2026
50%
Bullish
TickerSpark Score
54/100
▌ Mixed
20
Valuation
60
Profitability
55
Growth
80
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BTAI research report →

Analyst Price Target
$12.00+16138.2% vs. today

Range $1 – $25

Analyst RatingBuy
8 Buy6 Hold1 Sell

Price Chart

-98.40% · this period
$2.82$1.43$0.04Sep 25Mar 27Oct 01
52-Week Range2% of range
Low
$0.02
Current
$0.07
High
$2.87